Symbols

VERV(Delisted)

Verve Therapeutics·NASDAQ

--(--)

Is VERV undervalued or overvalued?

VERV scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its -6.42% ROE, -303.64% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 26.48% earnings growth, these metrics solidify its Neutral investment rating.